BCL2 and cancer: It has been clear for over a decade that the inhibition of apoptosis can contribute to the development for cancer, a finding first demonstrated in mice overexpressing both c-myc (driving the cell cycle) and Bcl-2 (which inhibits apoptosis) in the lymphatic system (Strasser et al, 1990).